Alterations of gut microbiota and its correlation with the liver metabolome in the process of ameliorating Parkinson's disease with Buyang Huanwu decoction

被引:4
|
作者
Hu, Jianran [1 ]
Li, Ping [1 ]
Zhao, Hongmei [1 ]
Ji, Pengyu [1 ]
Yang, Yanjun [1 ]
Ma, Jianhua [1 ]
Zhao, Xin [2 ,3 ]
机构
[1] Jinzhong Univ, Dept Biol Sci & Technol, Jinzhong 030619, Peoples R China
[2] Shanxi Med Univ, Key Lab Cellular Physiol, Minist Educ, Taiyuan 030001, Peoples R China
[3] Shanxi Med Univ, Dept Physiol, Taiyuan 030001, Peoples R China
关键词
Buyang Huanwu decoction; Parkinson's disease; Gut microbiota; Liver metabolome; Integrated analysis; PARABACTEROIDES-DISTASONIS; MOUSE MODEL; BRAIN AXIS; PHARMACOLOGY; RECOVERY; PLASMA; MARKER; CELLS; RATS;
D O I
10.1016/j.jep.2023.116893
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Buyang Huanwu decoction (BHD), a famous traditional Chinese medicine (TCM) formula, was first recorded in Qing Dynasty physician Qingren Wang's Yi Lin Gai Cuo. BHD has been widely utilized in the treatment of patients with neurological disorders, including Parkinson's disease (PD). However, the underlying mechanism has not been fully elucidated. In particular, little is known about the role of gut microbiota. Aim of the study: We aimed to reveal the alterations and functions of gut microbiota and its correlation with the liver metabolome in the process of improving PD with BHD. Materials and methods: The cecal contents were collected from PD mice treated with or without BHD. 16S rRNA gene sequencing was performed on an Illumina MiSeq-PE250 platform, and the ecological structure, dominant taxa, co-occurrence patterns, and function prediction of the gut microbial community were analyzed by multivariate statistical methods. The correlation between differential microbial communities in the gut and differentially accumulated metabolites in the liver was analyzed using Spearman's correlation analysis. Results: The abundance of Butyricimonas, Christensenellaceae, Coprococcus, Peptococcaceae, Odoribacteraceae, and Roseburia was altered significantly in the model group, which was by BHD. Ten genera, namely Dorea, unclassified_Lachnospiraceae, Oscillospira, unidentified_Ruminococcaceae, unclassified_Clostridiales, unidentified_Clostridiales, Bacteroides, unclassified_Prevotellaceae, unidentified_Rikenellaceae, and unidentified_S24-7, were identified as key bacterial communities. According to the function prediction of differential genera, the mRNA surveillance pathway might be a target of BHD. Integrated analysis of gut microbiota and the liver metabolome revealed that several gut microbiota genera such as Parabacteroides, Ochrobactrum, Acinetobacter, Clostridium, and Halomonas, were positively or negatively correlated with some nervous system-related metabolites, such as L-carnitine, Lpyroglutamic acid, oleic acid, and taurine. Conclusions: Gut microbiota might be a target of BHD in the process of ameliorating PD. Our findings provide novel insight into the mechanisms underlying the effects of BHD on PD and contribute to the development of TCM.
引用
收藏
页数:13
相关论文
共 34 条
  • [21] Positive effect of an electrolyzed reduced water on gut permeability, fecal microbiota and liver in an animal model of Parkinson's disease
    Bordoni, Laura
    Gabbianelli, Rosita
    Fedeli, Donatella
    Fiorini, Dennis
    Bergheim, Ina
    Jin, Cheng Jun
    Marinelli, Lisa
    Di Stefano, Antonio
    Nasuti, Cinzia
    PLOS ONE, 2019, 14 (10):
  • [22] Significance of LncRNA NEAT1 Alterations During Treatment of Nonalcoholic Fatty Liver Disease and its Association with Gut Microbiota
    Yu, Weiming
    Wang, Pengxiang
    Zhang, Qianwen
    He, Yiyu
    Wang, Likun
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2022, 18 (06) : 1287 - 1295
  • [23] Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease
    Koutzoumis, Dimitri N.
    Vergara, Macarena
    Pino, Jose
    Buddendorff, Julia
    Khoshbouei, Habibeh
    Mandel, Ronald J.
    Torres, Gonzalo E.
    EXPERIMENTAL NEUROLOGY, 2020, 325
  • [24] Leveraging sequence-based faecal microbial community survey data to identify alterations in gut microbiota among patients with Parkinson's disease
    Ji, Tianyi
    Huang, Hongyan
    Liu, Jiaxuan
    Peng, Tian
    Zhou, Xiazhu
    Tan, Qin
    Yuan, Jiaguo
    Hua, Huan
    Ding, Songtao
    Liu, Handeng
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2021, 53 (02) : 687 - 696
  • [25] Liver and White/Brown Fat Dystrophy Associates with Gut Microbiota and Metabolomic Alterations in 3xTg Alzheimer's Disease Mouse Model
    Guzzardi, Maria Angela
    La Rosa, Federica
    Campani, Daniela
    Carmen Collado, Maria
    Monleon, Daniel
    Insilla, Andrea Cacciato
    Tripodi, Maria
    Zega, Alessandro
    Dattilo, Alessia
    Brunetto, Maurizia Rossana
    Maffei, Margherita
    Bonino, Ferruccio
    Iozzo, Patricia
    METABOLITES, 2022, 12 (04)
  • [26] Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in Mice
    Zhuge, Aoxiang
    Li, Shengjie
    Lou, Pengcheng
    Wu, Wenrui
    Wang, Kaiceng
    Yuan, Yin
    Xia, Jiafeng
    Li, Bo
    Li, Lanjuan
    MICROBIOLOGY SPECTRUM, 2022, 10 (03):
  • [27] Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease
    Lai, Feng
    Jiang, Rong
    Xie, Wenjun
    Liu, Xinrong
    Tang, Yong
    Xiao, Hong
    Gao, Jieying
    Jia, Yan
    Bai, Qunhua
    NEUROCHEMICAL RESEARCH, 2018, 43 (10) : 1986 - 1999
  • [28] Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson’s Disease
    Feng Lai
    Rong Jiang
    Wenjun Xie
    Xinrong Liu
    Yong Tang
    Hong Xiao
    Jieying Gao
    Yan Jia
    Qunhua Bai
    Neurochemical Research, 2018, 43 : 1986 - 1999
  • [29] Integrated analysis of the transcriptome and its interaction with the metabolome in metabolic associated fatty liver disease: Gut microbiome signatures, correlation networks, and effect of PNPLA3 genotype
    Mascardi, Maria Florencia
    Mazzini, Flavia Noelia
    Suarez, Barbara
    Ruda, Vera M.
    Marciano, Sebastian
    Casciato, Paola
    Narvaez, Adrian
    Haddad, Leila
    Anders, Margarita
    Orozco, Federico
    Tamaroff, Ana Jesica
    Cook, Frank
    Gounarides, John
    Gutt, Susana
    Gadano, Adrian
    Garcia, Celia Mendez
    Marro, Martin L.
    Steinhardt, Alberto Penas
    Trinks, Julieta
    PROTEOMICS, 2023, 23 (18)
  • [30] Association of fecal short-chain fatty acids with clinical severity and gut microbiota in essential tremor and its difference from Parkinson's disease
    Huang, Pei
    Zhang, Pingchen
    Du, Juanjuan
    Gao, Chao
    Liu, Jin
    Tan, Yuyan
    Chen, Shengdi
    NPJ PARKINSONS DISEASE, 2023, 9 (01)